Nerissa Kreher, Chief Medical Officer at Entrada Therapeutics, Inc. (TRDA), sold 2,586 shares at $11.22 ($28K) on 2023-03-02, disclosed to the SEC on 2023-03-03.
Scheduled sale ($28k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.49 | 1,477 | $15K | 54.8% |
| 2 | $11.22 | 164 | $2K | 6.5% |
| 3 | $11.60 | 945 | $11K | 38.7% |
| Total | $10.94 avg | 2,586 | $28K | 100% |
| Filing → |
| TRDA | SELL | 2023-08-04 | $771K | — | Filing → |
| TRDA | SELL | 2023-01-03 | $70K | — | Filing → |
| TRDA | SELL | 2022-10-27 | $537K | — | Filing → |